Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.
Hoffknecht P, Tufman A, Wehler T, Pelzer T, Wiewrodt R, Schütz M, Serke M, Stöhlmacher-Williams J, Märten A, Maria Huber R, Dickgreber NJ; Afatinib Compassionate Use Consortium (ACUC). Hoffknecht P, et al. J Thorac Oncol. 2015 Jan;10(1):156-63. doi: 10.1097/JTO.0000000000000380. J Thorac Oncol. 2015. PMID: 25247337 Free PMC article.
Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis.
Overbeck TR, Cron DA, Schmitz K, Rittmeyer A, Körber W, Hugo S, Schnalke J, Lukat L, Hugo T, Hinterthaner M, Reuter-Jessen K, Rosenthal T, Moecks J, Bleckmann A, Schildhaus HU. Overbeck TR, et al. Among authors: korber w. Transl Lung Cancer Res. 2020 Jun;9(3):603-616. doi: 10.21037/tlcr-19-339. Transl Lung Cancer Res. 2020. PMID: 32676323 Free PMC article.
Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years' practice.
Guhlich M, Maag TE, Dröge LH, El Shafie RA, Hille A, Donath S, Schirmer MA, Knaus O, Nauck F, Overbeck TR, Hinterthaner M, Körber W, Andreas S, Rittmeyer A, Leu M, Rieken S. Guhlich M, et al. Among authors: korber w. Strahlenther Onkol. 2022 Dec;198(12):1072-1081. doi: 10.1007/s00066-022-01952-z. Epub 2022 May 12. Strahlenther Onkol. 2022. PMID: 35552767 Free PMC article.
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Griesinger F, Sebastian M, Brueckl WM, Hummel HD, Jaeschke B, Kern J, Wesseler C, Jänicke M, Fleitz A, Zacharias S, Hipper A, Groth A, Weichert W, Dörfel S, Petersen V, Schröder J, Wilke J, Eberhardt WEE, Thomas M; CRISP Registry Group. Griesinger F, et al. JTO Clin Res Rep. 2023 Dec 25;5(4):100626. doi: 10.1016/j.jtocrr.2023.100626. eCollection 2024 Apr. JTO Clin Res Rep. 2023. PMID: 38586301 Free PMC article.
The delineation of target volumes for radiotherapy of lung cancer patients.
Vorwerk H, Beckmann G, Bremer M, Degen M, Dietl B, Fietkau R, Gsänger T, Hermann RM, Alfred Herrmann MK, Höller U, van Kampen M, Körber W, Maier B, Martin T, Metz M, Richter R, Siekmeyer B, Steder M, Wagner D, Hess CF, Weiss E, Christiansen H. Vorwerk H, et al. Among authors: korber w. Radiother Oncol. 2009 Jun;91(3):455-60. doi: 10.1016/j.radonc.2009.03.014. Epub 2009 Mar 30. Radiother Oncol. 2009. PMID: 19339069
Make Another Attempt at Weaning.
Körber W, Kleiß L, Höhl CF, Knaak M. Körber W, et al. Dtsch Arztebl Int. 2020 Aug 3;117(31-32):544. doi: 10.3238/arztebl.2020.0544a. Dtsch Arztebl Int. 2020. PMID: 33087244 Free PMC article. No abstract available.
19 results